DIN 02506009 — ZEPOSIA 0.46 MG; 0.23 MG
ZEPOSIA is a capsule of Ozanimod marketed by BRISTOL-MYERS SQUIBB CANADA. The full Ozanimod monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02506009
- Brand name
- ZEPOSIA
- Active ingredient
- Ozanimod
- Strength
- 0.46 MG; 0.23 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- BRISTOL-MYERS SQUIBB CANADA
- Health Canada status
- MARKETED
- Drug class
- Sphingosine 1-phosphate (S1P) receptor modulator
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Ozanimod products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02505991 | ZEPOSIA | 0.92 MG | CAPSULE | BRISTOL-MYERS SQUIBB CANADA | MARKETED |